Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate
Background Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time i...
Saved in:
Published in | Journal of magnetic resonance imaging Vol. 56; no. 1; pp. 184 - 195 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.07.2022
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first‐line screening modality.
Purpose
To accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction.
Study Type
Retrospective.
Subjects
One hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI.
Field Strength/Sequence
3.0 T; a T2 turbo spin echo (TSE) T2‐weighted image (T2WI) sequence in axial and coronal planes, and axial echo‐planar diffusion‐weighted imaging (DWI).
Assessment
Four abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under‐sampled biparametric MRIs (bp‐MRI), and standard bp‐MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4‐fold T2WI, 3‐fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non‐diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp‐MRI—which additionally included calculated B1500 seconds/mm2, and apparent diffusion coefficient map—according to the Prostate Imaging Reporting and Data System (PI‐RADS v2.1), for both VN and standard reconstructions. Accuracy of PI‐RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under‐sampled biparametric exam was also computed.
Statistical Tests
One‐sided Wilcoxon signed‐rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp‐MRI. A P‐value of <0.05 was considered statistically significant.
Results
Three of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI‐RADS ≥3 lesions identified on standard vs. VN bp‐MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam.
Data Conclusion
Diagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI.
Level of Evidence
3
Technical Efficacy
Stage 5 |
---|---|
AbstractList | Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate-specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first-line screening modality.
To accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction.
Retrospective.
One hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI.
3.0 T; a T2 turbo spin echo (TSE) T2-weighted image (T2WI) sequence in axial and coronal planes, and axial echo-planar diffusion-weighted imaging (DWI).
Four abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under-sampled biparametric MRIs (bp-MRI), and standard bp-MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm
and B1000 seconds/mm (4-fold T2WI, 3-fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non-diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp-MRI-which additionally included calculated B1500 seconds/mm
, and apparent diffusion coefficient map-according to the Prostate Imaging Reporting and Data System (PI-RADS v2.1), for both VN and standard reconstructions. Accuracy of PI-RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under-sampled biparametric exam was also computed.
One-sided Wilcoxon signed-rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp-MRI. A P-value of <0.05 was considered statistically significant.
Three of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm
(Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm
(Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI-RADS ≥3 lesions identified on standard vs. VN bp-MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam.
Diagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI.
3 TECHNICAL EFFICACY: Stage 5. Background Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first‐line screening modality. Purpose To accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction. Study Type Retrospective. Subjects One hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI. Field Strength/Sequence 3.0 T; a T2 turbo spin echo (TSE) T2‐weighted image (T2WI) sequence in axial and coronal planes, and axial echo‐planar diffusion‐weighted imaging (DWI). Assessment Four abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under‐sampled biparametric MRIs (bp‐MRI), and standard bp‐MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4‐fold T2WI, 3‐fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non‐diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp‐MRI—which additionally included calculated B1500 seconds/mm2, and apparent diffusion coefficient map—according to the Prostate Imaging Reporting and Data System (PI‐RADS v2.1), for both VN and standard reconstructions. Accuracy of PI‐RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under‐sampled biparametric exam was also computed. Statistical Tests One‐sided Wilcoxon signed‐rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp‐MRI. A P‐value of <0.05 was considered statistically significant. Results Three of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI‐RADS ≥3 lesions identified on standard vs. VN bp‐MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam. Data Conclusion Diagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI. Level of Evidence 3 Technical Efficacy Stage 5 Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate-specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first-line screening modality.BACKGROUNDEarly diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate-specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first-line screening modality.To accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction.PURPOSETo accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction.Retrospective.STUDY TYPERetrospective.One hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI.SUBJECTSOne hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI.3.0 T; a T2 turbo spin echo (TSE) T2-weighted image (T2WI) sequence in axial and coronal planes, and axial echo-planar diffusion-weighted imaging (DWI).FIELD STRENGTH/SEQUENCE3.0 T; a T2 turbo spin echo (TSE) T2-weighted image (T2WI) sequence in axial and coronal planes, and axial echo-planar diffusion-weighted imaging (DWI).Four abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under-sampled biparametric MRIs (bp-MRI), and standard bp-MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4-fold T2WI, 3-fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non-diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp-MRI-which additionally included calculated B1500 seconds/mm2 , and apparent diffusion coefficient map-according to the Prostate Imaging Reporting and Data System (PI-RADS v2.1), for both VN and standard reconstructions. Accuracy of PI-RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under-sampled biparametric exam was also computed.ASSESSMENTFour abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under-sampled biparametric MRIs (bp-MRI), and standard bp-MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4-fold T2WI, 3-fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non-diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp-MRI-which additionally included calculated B1500 seconds/mm2 , and apparent diffusion coefficient map-according to the Prostate Imaging Reporting and Data System (PI-RADS v2.1), for both VN and standard reconstructions. Accuracy of PI-RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under-sampled biparametric exam was also computed.One-sided Wilcoxon signed-rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp-MRI. A P-value of <0.05 was considered statistically significant.STATISTICAL TESTSOne-sided Wilcoxon signed-rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp-MRI. A P-value of <0.05 was considered statistically significant.Three of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI-RADS ≥3 lesions identified on standard vs. VN bp-MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam.RESULTSThree of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI-RADS ≥3 lesions identified on standard vs. VN bp-MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam.Diagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI.DATA CONCLUSIONDiagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI.3 TECHNICAL EFFICACY: Stage 5.LEVEL OF EVIDENCE3 TECHNICAL EFFICACY: Stage 5. BackgroundEarly diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for clinically significant PCa. While prostate magnetic resonance imaging (MRI) has demonstrated value for the diagnosis of PCa, the acquisition time is too long for a first‐line screening modality.PurposeTo accelerate prostate MRI exams, utilizing a variational network (VN) for image reconstruction.Study TypeRetrospective.SubjectsOne hundred and thirteen subjects (train/val/test: 70/13/30) undergoing prostate MRI.Field Strength/Sequence3.0 T; a T2 turbo spin echo (TSE) T2‐weighted image (T2WI) sequence in axial and coronal planes, and axial echo‐planar diffusion‐weighted imaging (DWI).AssessmentFour abdominal radiologists evaluated the image quality of VN reconstructions of retrospectively under‐sampled biparametric MRIs (bp‐MRI), and standard bp‐MRI reconstructions for 20 test subjects (studies). The studies included axial and coronal T2WI, DWI B50 seconds/mm2 and B1000 seconds/mm (4‐fold T2WI, 3‐fold DWI), all of which were evaluated separately for image quality on a Likert scale (1: non‐diagnostic to 5: excellent quality). In another 10 test subjects, three readers graded lesions on bp‐MRI—which additionally included calculated B1500 seconds/mm2, and apparent diffusion coefficient map—according to the Prostate Imaging Reporting and Data System (PI‐RADS v2.1), for both VN and standard reconstructions. Accuracy of PI‐RADS ≥3 for clinically significant cancer was computed. Projected scan time of the retrospectively under‐sampled biparametric exam was also computed.Statistical TestsOne‐sided Wilcoxon signed‐rank test was used for comparison of image quality. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for lesion detection and grading. Generalized estimating equation with cluster effect was used to compare differences between standard and VN bp‐MRI. A P‐value of <0.05 was considered statistically significant.ResultsThree of four readers rated no significant difference for overall quality between the standard and VN axial T2WI (Reader 1: 4.00 ± 0.56 (Standard), 3.90 ± 0.64 (VN) P = 0.33; Reader 2: 4.35 ± 0.74 (Standard), 3.80 ± 0.89 (VN) P = 0.003; Reader 3: 4.60 ± 0.50 (Standard), 4.55 ± 0.60 (VN) P = 0.39; Reader 4: 3.65 ± 0.99 (Standard), 3.60 ± 1.00 (VN) P = 0.38). All four readers rated no significant difference for overall quality between standard and VN DWI B1000 seconds/mm2 (Reader 1: 2.25 ± 0.62 (Standard), 2.45 ± 0.75 (VN) P = 0.96; Reader 2: 3.60 ± 0.92 (Standard), 3.55 ± 0.82 (VN) P = 0.40; Reader 3: 3.85 ± 0.72 (Standard), 3.55 ± 0.89 (VN) P = 0.07; Reader 4: 4.70 ± 0.76 (Standard); 4.60 ± 0.73 (VN) P = 0.17) and three of four readers rated no significant difference for overall quality between standard and VN DWI B50 seconds/mm2 (Reader 1: 3.20 ± 0.70 (Standard), 3.40 ± 0.75 (VN) P = 0.98; Reader 2: 2.85 ± 0.81 (Standard), 3.00 ± 0.79 (VN) P = 0.93; Reader 3: 4.45 ± 0.72 (Standard), 4.05 ± 0.69 (VN) P = 0.02; Reader 4: 4.50 ± 0.69 (Standard), 4.45 ± 0.76 (VN) P = 0.50). In the lesion evaluation study, there was no significant difference in the number of PI‐RADS ≥3 lesions identified on standard vs. VN bp‐MRI (P = 0.92, 0.59, 0.87) with similar sensitivity and specificity for clinically significant cancer. The average scan time of the standard clinical biparametric exam was 11.8 minutes, and this was projected to be 3.2 minutes for the accelerated exam.Data ConclusionDiagnostic accelerated biparametric prostate MRI exams can be performed using deep learning methods in <4 minutes, potentially enabling rapid screening prostate MRI.Level of Evidence3Technical EfficacyStage 5 |
Author | Petrocelli, Robert Knoll, Florian Qian, Kun Johnson, Patricia M. Smereka, Paul Keerthivasan, Mahesh B. Melamud, Kira Tong, Angela Chandarana, Hersh Donthireddy, Awani |
AuthorAffiliation | 1 Center for Advanced Imaging Innovation and Research (CAI2R), Department of Radiology, New York University School of Medicine, New York, NY, USA 2 Division of Biostatistics, Department of Population Health, New York University School of Medicine, New York, NY, USA 3 Siemens Medical Solutions USA Inc, Malvern, PA, United States |
AuthorAffiliation_xml | – name: 3 Siemens Medical Solutions USA Inc, Malvern, PA, United States – name: 2 Division of Biostatistics, Department of Population Health, New York University School of Medicine, New York, NY, USA – name: 1 Center for Advanced Imaging Innovation and Research (CAI2R), Department of Radiology, New York University School of Medicine, New York, NY, USA |
Author_xml | – sequence: 1 givenname: Patricia M. orcidid: 0000-0003-1547-9969 surname: Johnson fullname: Johnson, Patricia M. email: patricia.johnson3@nyulangone.org organization: New York University School of Medicine – sequence: 2 givenname: Angela surname: Tong fullname: Tong, Angela organization: New York University School of Medicine – sequence: 3 givenname: Awani surname: Donthireddy fullname: Donthireddy, Awani organization: New York University School of Medicine – sequence: 4 givenname: Kira surname: Melamud fullname: Melamud, Kira organization: New York University School of Medicine – sequence: 5 givenname: Robert surname: Petrocelli fullname: Petrocelli, Robert organization: New York University School of Medicine – sequence: 6 givenname: Paul surname: Smereka fullname: Smereka, Paul organization: New York University School of Medicine – sequence: 7 givenname: Kun surname: Qian fullname: Qian, Kun organization: New York University School of Medicine – sequence: 8 givenname: Mahesh B. surname: Keerthivasan fullname: Keerthivasan, Mahesh B. organization: Siemens Medical Solutions USA Inc – sequence: 9 givenname: Hersh surname: Chandarana fullname: Chandarana, Hersh organization: New York University School of Medicine – sequence: 10 givenname: Florian surname: Knoll fullname: Knoll, Florian organization: New York University School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34877735$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kV9rFDEUxYO02Hb1xQ8gAV-kMDV_JjOTF6G21W7Zoiz6HLKZm90sM8k2mVH225t121KL-JQL-d3DPeecoAMfPCD0hpIzSgj7sO6jO2MNYeULdEwFYwUTTXWQZyJ4QRtSH6GTlNaEEClL8RId8bKp65qLY6QuATZ4Bjp655d4Dib4NMTRDC54fOX1ooOEr91y1W3xuTHQQdQDtPiT2-ioexiiM_h2jqe9Xu4UgsXDCvC3GNKQwVfo0Oouwev7d4J-fL76fnFdzL5-mV6czwojaFkWDYFaUEutNYYSaqHiFFohoTKSt60WsuZtVXPKpZF2wbkQlmhZaRBAaGYm6ONedzMuemgN-CHqTm2i63XcqqCd-vvHu5Vahp9K0po0fCfw_l4ghrsR0qB6l7LdTnsIY1KsIg1lTJZlRt89Q9dhjD7by1S2IUiZT52gt08vejzlIfsMnO4Bk7NKEewjQonaFat2xao_xWaYPIONy_nmkrIb1_17he5XfrkOtv8RVze38-l-5zcgE7Yu |
CitedBy_id | crossref_primary_10_1097_RLI_0000000000001110 crossref_primary_10_1016_j_ejrad_2023_110757 crossref_primary_10_1097_RLI_0000000000001171 crossref_primary_10_1002_mrm_30105 crossref_primary_10_1002_jmri_28602 crossref_primary_10_1002_jmri_28603 crossref_primary_10_1038_s41598_024_79348_5 crossref_primary_10_1016_j_acra_2024_06_048 crossref_primary_10_1016_j_rcl_2023_06_006 crossref_primary_10_1016_j_ejrad_2023_111017 crossref_primary_10_1016_j_ejrad_2023_110887 crossref_primary_10_1016_j_ejrad_2025_111997 crossref_primary_10_1007_s11547_024_01861_4 crossref_primary_10_1093_dmfr_twae063 crossref_primary_10_2214_AJR_24_32588 crossref_primary_10_1038_s41598_025_94777_6 crossref_primary_10_1007_s00330_024_10776_7 crossref_primary_10_1007_s00261_024_04396_4 crossref_primary_10_1097_RLI_0000000000000997 crossref_primary_10_1177_02841851231192786 crossref_primary_10_1177_02841851241273114 crossref_primary_10_3390_cancers15030578 crossref_primary_10_1007_s00256_023_04321_8 crossref_primary_10_1016_j_acra_2023_05_010 crossref_primary_10_1148_radiol_230427 crossref_primary_10_1002_jmri_29269 crossref_primary_10_1259_bjr_20211378 crossref_primary_10_6009_jjrt_2023_2260 crossref_primary_10_1002_jmri_28577 crossref_primary_10_1002_mrm_29485 crossref_primary_10_1016_j_ejro_2024_100588 crossref_primary_10_1038_s41597_024_03252_w crossref_primary_10_1016_j_ejro_2025_100635 crossref_primary_10_1093_bjr_tqae093 crossref_primary_10_1109_ACCESS_2023_3344456 crossref_primary_10_1148_radiol_220425 crossref_primary_10_1002_jmri_29025 crossref_primary_10_1148_radiol_241009 crossref_primary_10_1016_j_acra_2023_06_035 crossref_primary_10_1016_j_ejrad_2023_110953 crossref_primary_10_3390_cancers14235741 crossref_primary_10_1148_radiol_233337 crossref_primary_10_1186_s13244_024_01686_9 crossref_primary_10_1007_s00330_023_09781_z |
Cites_doi | 10.1148/radiol.2017170129 10.14740/wjon1191 10.1002/mrm.26977 10.1117/1.JMI.5.4.044507 10.1002/mrm.21391 10.1016/j.juro.2015.10.140 10.1109/TMI.2018.2865356 10.1148/radiol.2018180445 10.1002/jmri.23689 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S 10.1109/TBME.2018.2821699 10.1016/j.ejrad.2021.109600 10.2214/AJR.11.8446 10.1001/jama.2018.3712 10.1007/978-3-030-59713-9_7 10.1016/j.euo.2018.03.008 10.1002/mrm.10171 10.1001/jamaoncol.2020.7456 10.2214/AJR.20.23313 10.1016/j.eururo.2018.11.031 10.1038/s41598-019-55972-4 10.1007/978-3-319-24574-4_28 10.1109/TIP.2003.819861 10.1097/JU.0000000000000713 10.1016/S0140-6736(16)32401-1 10.1007/s11934-015-0507-9 10.3310/hta22390 10.1016/j.ejca.2011.06.055 10.1111/j.1464-410X.2012.11611.x 10.1002/mrm.24751 10.1001/jama.1994.03510290050036 10.1016/j.eururo.2019.05.029 10.1056/NEJMoa1801993 10.1001/jama.2014.17942 |
ContentType | Journal Article |
Copyright | 2021 International Society for Magnetic Resonance in Medicine. 2022 International Society for Magnetic Resonance in Medicine |
Copyright_xml | – notice: 2021 International Society for Magnetic Resonance in Medicine. – notice: 2022 International Society for Magnetic Resonance in Medicine |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7TK 8FD FR3 K9. P64 7X8 5PM |
DOI | 10.1002/jmri.28024 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-2586 |
EndPage | 195 |
ExternalDocumentID | PMC9170839 34877735 10_1002_jmri_28024 JMRI28024 |
Genre | article Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Institutes of Health funderid: R01 EB024532 – fundername: National Cancer Institute funderid: R21 CA256324‐01; P41EB017183 – fundername: NIBIB NIH HHS grantid: R01 EB024532 – fundername: NIBIB NIH HHS grantid: P41 EB017183 – fundername: NCI NIH HHS grantid: R21 CA256324-01 – fundername: NCI NIH HHS grantid: P41EB017183 – fundername: NCI NIH HHS grantid: R21 CA256324 |
GroupedDBID | --- -DZ .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HDBZQ HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V8K V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QO 7TK 8FD FR3 K9. P64 7X8 5PM |
ID | FETCH-LOGICAL-c5144-80e751f1ffcc101fe631ed59e6c93dda5973d673139c9fb3355f0a96ae5e01c93 |
IEDL.DBID | DR2 |
ISSN | 1053-1807 1522-2586 |
IngestDate | Thu Aug 21 18:37:48 EDT 2025 Fri Jul 11 03:35:54 EDT 2025 Fri Jul 25 12:11:05 EDT 2025 Mon Jul 21 05:26:26 EDT 2025 Thu Apr 24 22:57:21 EDT 2025 Tue Jul 01 03:56:52 EDT 2025 Wed Jan 22 16:23:57 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | deep learning prostate MRI image reconstruction accelerated imaging |
Language | English |
License | 2021 International Society for Magnetic Resonance in Medicine. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5144-80e751f1ffcc101fe631ed59e6c93dda5973d673139c9fb3355f0a96ae5e01c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-1547-9969 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/9170839 |
PMID | 34877735 |
PQID | 2675150467 |
PQPubID | 1006400 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9170839 proquest_miscellaneous_2608122944 proquest_journals_2675150467 pubmed_primary_34877735 crossref_primary_10_1002_jmri_28024 crossref_citationtrail_10_1002_jmri_28024 wiley_primary_10_1002_jmri_28024_JMRI28024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2022 |
PublicationDateYYYYMMDD | 2022-07-01 |
PublicationDate_xml | – month: 07 year: 2022 text: July 2022 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Nashville |
PublicationSubtitle | JMRI |
PublicationTitle | Journal of magnetic resonance imaging |
PublicationTitleAlternate | J Magn Reson Imaging |
PublicationYear | 2022 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2021; 7 2019; 9 2015; 16 2019; 75 2019; 10 2019; 76 2018; 289 1994; 271 2019; 38 2020; 203 1999; 42 2018; 22 2018; 65 2007; 58 2015; 9351 2002; 47 2013; 37 2012; 199 2018; 5 2015; 313 2018; 1 2021; 137 2020 2018; 378 2004; 13 2020; 215 2020; 28 2013; 111 2018; 319 2017; 285 2014 2011; 47 2017; 389 2014; 71 2016; 195 2018; 79 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_21_1 e_1_2_6_20_1 O'shea A (e_1_2_6_33_1) 2020; 28 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 58 start-page: 1182 issue: 6 year: 2007 end-page: 1195 article-title: Sparse MRI: The application of compressed sensing for rapid MR imaging publication-title: Magn Reson Med – volume: 271 start-page: 368 issue: 5 year: 1994 end-page: 374 article-title: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer publication-title: JAMA – volume: 28 issue: 2450 year: 2020 article-title: Initial experience in abbreviated T2‐weighted prostate MRI using a deep learning reconstruction publication-title: Proc Intl Soc Mag Reson Med – volume: 195 start-page: 1428 issue: 5 year: 2016 end-page: 1435 article-title: The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer publication-title: J Urol – volume: 22 start-page: 1 issue: 39 year: 2018 end-page: 176 article-title: Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound‐guided prostate biopsy alone: The PROMIS study publication-title: Health Technol Assess – volume: 37 start-page: 48 issue: 1 year: 2013 end-page: 58 article-title: Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: Could standardization lead to improved utilization of imaging within the diagnostic pathway? publication-title: J Magn Reson Imaging – volume: 10 start-page: 63 issue: 2 year: 2019 end-page: 89 article-title: Epidemiology of prostate cancer publication-title: World J Oncol – volume: 203 start-page: 1122 issue: 6 year: 2020 end-page: 1127 article-title: Long‐term outcomes of active surveillance for prostate cancer: The Memorial Sloan Kettering Cancer Center experience publication-title: J Urol – volume: 7 start-page: 395 issue: 3 year: 2021 article-title: Population‐based prostate cancer screening with magnetic resonance imaging or ultrasonography: The IP1‐PROSTAGRAM study publication-title: JAMA Oncol – volume: 13 start-page: 600 issue: 4 year: 2004 end-page: 612 article-title: Image quality assessment: From error visibility to structural similarity publication-title: IEEE Trans Image Process – volume: 42 start-page: 952 issue: 5 year: 1999 end-page: 962 article-title: SENSE: sensitivity encoding for fast MRI publication-title: Magn Reson Med – volume: 47 start-page: 1202 issue: 6 year: 2002 end-page: 1210 article-title: Generalized autocalibrating partially parallel acquisitions (GRAPPA) publication-title: Magn Reson Med – volume: 215 start-page: 1421 year: 2020 end-page: 1429 article-title: Using deep learning to accelerate knee MRI at 3 T: Results of an interchangeability study publication-title: AJR Am J Roentgenol – volume: 111 start-page: 753 issue: 5 year: 2013 end-page: 760 article-title: Prognostic Gleason grade grouping: Data based on the modified Gleason scoring system publication-title: BJU Int – volume: 1 start-page: 208 issue: 3 year: 2018 end-page: 214 article-title: Clinical utility of multiparametric magnetic resonance imaging as the first‐line tool for men with high clinical suspicion of prostate cancer publication-title: Eur Urol Oncol – volume: 65 start-page: 1985 issue: 9 year: 2018 end-page: 1995 article-title: Deep residual learning for accelerated MRI using magnitude and phase networks publication-title: IEEE Trans Biomed Eng – year: 2014 – volume: 285 start-page: 493 issue: 2 year: 2017 end-page: 505 article-title: Abbreviated biparametric prostate MR imaging in men with elevated prostate‐specific antigen publication-title: Radiology – volume: 47 start-page: 2698 issue: 18 year: 2011 end-page: 2705 article-title: False‐positive screening results in the European randomized study of screening for prostate cancer publication-title: Eur J Cancer – volume: 313 start-page: 390 issue: 4 year: 2015 end-page: 397 article-title: Comparison of MR/ultrasound fusion‐guided biopsy with ultrasound‐guided biopsy for the diagnosis of prostate cancer publication-title: JAMA – volume: 16 start-page: 42 issue: 6 year: 2015 article-title: The role of MRI in active surveillance for prostate cancer publication-title: Curr Urol Rep – volume: 389 start-page: 815 issue: 10071 year: 2017 end-page: 822 article-title: Diagnostic accuracy of multi‐parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study publication-title: Lancet – volume: 38 start-page: 394 issue: 2 year: 2019 end-page: 405 article-title: MoDL: Model‐based deep learning architecture for inverse problems publication-title: IEEE Trans Med Imaging – volume: 9 start-page: 19518 issue: 1 year: 2019 article-title: Prostate cancer detection using deep convolutional neural networks publication-title: Sci Rep – volume: 79 start-page: 3055 issue: 6 year: 2018 end-page: 3071 article-title: Learning a variational network for reconstruction of accelerated MRI data publication-title: Magn Reson Med – volume: 289 start-page: 366 issue: 2 year: 2018 end-page: 373 article-title: Variable‐density single‐shot fast spin‐echo MRI with deep learning reconstruction by using variational networks publication-title: Radiology – volume: 76 start-page: 574 issue: 5 year: 2019 end-page: 581 article-title: High diagnostic performance of short magnetic resonance imaging protocols for prostate cancer detection in biopsy‐naïve men: The next step in magnetic resonance imaging accessibility publication-title: Eur Urol – year: 2020 – volume: 137 year: 2021 article-title: Deep learning‐accelerated T2‐weighted imaging of the prostate: Reduction of acquisition time and improvement of image quality publication-title: Eur J Radiol – volume: 5 issue: 4 year: 2018 article-title: Prostate cancer detection from multi‐institution multiparametric MRIs using deep convolutional neural networks publication-title: J Med Imaging – volume: 319 start-page: 1914 issue: 18 year: 2018 article-title: Prostate‐specific antigen‐based screening for prostate cancer: Evidence report and systematic review for the US Preventive Services Task Force publication-title: JAMA – volume: 378 start-page: 1767 issue: 19 year: 2018 end-page: 1777 article-title: MRI‐targeted or standard biopsy for prostate‐cancer diagnosis publication-title: N Engl J Med – volume: 75 start-page: 712 issue: 5 year: 2019 end-page: 720 article-title: Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging publication-title: Eur Urol – volume: 71 start-page: 990 issue: 3 year: 2014 end-page: 1001 article-title: ESPIRiT—An eigenvalue approach to autocalibrating parallel MRI: Where SENSE meets GRAPPA publication-title: Magn Reson Med – volume: 199 start-page: 830 issue: 4 year: 2012 end-page: 837 article-title: Prostate cancer: Multiparametric MRI for index lesion localization—A multiple‐reader study publication-title: AJR Am J Roentgenol – volume: 9351 year: 2015 – ident: e_1_2_6_14_1 doi: 10.1148/radiol.2017170129 – ident: e_1_2_6_2_1 doi: 10.14740/wjon1191 – ident: e_1_2_6_23_1 doi: 10.1002/mrm.26977 – ident: e_1_2_6_36_1 doi: 10.1117/1.JMI.5.4.044507 – ident: e_1_2_6_19_1 doi: 10.1002/mrm.21391 – ident: e_1_2_6_10_1 doi: 10.1016/j.juro.2015.10.140 – ident: e_1_2_6_20_1 doi: 10.1109/TMI.2018.2865356 – ident: e_1_2_6_25_1 doi: 10.1148/radiol.2018180445 – ident: e_1_2_6_30_1 doi: 10.1002/jmri.23689 – ident: e_1_2_6_18_1 doi: 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S – ident: e_1_2_6_22_1 doi: 10.1109/TBME.2018.2821699 – ident: e_1_2_6_32_1 doi: 10.1016/j.ejrad.2021.109600 – ident: e_1_2_6_8_1 doi: 10.2214/AJR.11.8446 – ident: e_1_2_6_3_1 doi: 10.1001/jama.2018.3712 – ident: e_1_2_6_21_1 doi: 10.1007/978-3-030-59713-9_7 – ident: e_1_2_6_11_1 doi: 10.1016/j.euo.2018.03.008 – ident: e_1_2_6_17_1 doi: 10.1002/mrm.10171 – ident: e_1_2_6_16_1 doi: 10.1001/jamaoncol.2020.7456 – ident: e_1_2_6_24_1 doi: 10.2214/AJR.20.23313 – ident: e_1_2_6_9_1 doi: 10.1016/j.eururo.2018.11.031 – ident: e_1_2_6_37_1 doi: 10.1038/s41598-019-55972-4 – ident: e_1_2_6_29_1 doi: 10.1007/978-3-319-24574-4_28 – ident: e_1_2_6_27_1 – ident: e_1_2_6_28_1 doi: 10.1109/TIP.2003.819861 – ident: e_1_2_6_35_1 doi: 10.1097/JU.0000000000000713 – ident: e_1_2_6_7_1 doi: 10.1016/S0140-6736(16)32401-1 – ident: e_1_2_6_34_1 doi: 10.1007/s11934-015-0507-9 – ident: e_1_2_6_12_1 doi: 10.3310/hta22390 – ident: e_1_2_6_4_1 doi: 10.1016/j.ejca.2011.06.055 – volume: 28 issue: 2450 year: 2020 ident: e_1_2_6_33_1 article-title: Initial experience in abbreviated T2‐weighted prostate MRI using a deep learning reconstruction publication-title: Proc Intl Soc Mag Reson Med – ident: e_1_2_6_31_1 doi: 10.1111/j.1464-410X.2012.11611.x – ident: e_1_2_6_26_1 doi: 10.1002/mrm.24751 – ident: e_1_2_6_5_1 doi: 10.1001/jama.1994.03510290050036 – ident: e_1_2_6_15_1 doi: 10.1016/j.eururo.2019.05.029 – ident: e_1_2_6_6_1 doi: 10.1056/NEJMoa1801993 – ident: e_1_2_6_13_1 doi: 10.1001/jama.2014.17942 |
SSID | ssj0009945 |
Score | 2.5594566 |
Snippet | Background
Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for... Early diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate-specific antigen is a suboptimal screening test for clinically... BackgroundEarly diagnosis and treatment of prostate cancer (PCa) can be curative; however, prostate‐specific antigen is a suboptimal screening test for... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 184 |
SubjectTerms | accelerated imaging Antigens Cancer Computation Deep Learning Diagnosis Diagnostic systems Diffusion coefficient Diffusion Magnetic Resonance Imaging - methods Evaluation Field strength Humans Image processing Image quality Image reconstruction Lesions Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Mathematical analysis Medical imaging Prostate Prostate - diagnostic imaging Prostate - pathology Prostate cancer prostate MRI Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - pathology Rank tests Retrospective Studies Screening Sensitivity Statistical analysis Statistical tests |
Title | Deep Learning Reconstruction Enables Highly Accelerated Biparametric MR Imaging of the Prostate |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.28024 https://www.ncbi.nlm.nih.gov/pubmed/34877735 https://www.proquest.com/docview/2675150467 https://www.proquest.com/docview/2608122944 https://pubmed.ncbi.nlm.nih.gov/PMC9170839 |
Volume | 56 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED8hHqa9bGxjWwdMnuCFSSmNnTi1xEu3gQCpCFUg8TJFjj-grE3RCg_jr-fOSdMV0KTxFsmXD9t3vt_F598BbAnlRaYKHkmv0ijRUkZFYtNIC2EziRrjAtlz_1genCVH5-n5EuzOzsJU_BDNDzeyjLBek4HrYrozJw29Gv8etnkXfQwuwJSsRYhoMOeOUipUKEb8IKK428kablK-M7910Rs9gpiPMyX_RrDBBe2_hp-zj68yT361b2-Ktrl7wOv43N6twKsam7JepUxvYMmVb-FFv959fwf5D-euWc3IesEocp3zz7K9cApryihzZPSH9YxBj0ZEFJZ9GxLD-JiKdxnWH7DDcaiNxCaeIf5kJ3TyBAVX4Wx_7_T7QVQXaIgM4qwEvZvL0tjH3huDpu2dFLGzqXLSKGGtxmBFWJkJRJlG-UIgtvEdraR2qevEKPMelstJ6T4Cow1P7j2Gc9YlsZVaJ3HsEbtJRDCiUC3Ynk1Ubmr2ciqiMcor3mWe04jlYcRasNnIXlecHU9Krc_mO6_tdppzjJ8QIqP3aMGXphktjrZRdOkmtySDMIpzleAjPlTq0bxGJMSvKNIWZAuK0wgQm_diSzm8DKzeGDcjHMaOfg168Y8vz4_6g8Nw9el_hNfgJaezGyHXeB2WUT_cBiKqm-JzsJx7k48dGw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3fT9swEMdPDKRtLzD2s4NtnraXTUpp7MTBj2yAWkbQVIHEm5X4x9aNpojCw_jruXNCSgFN2t4q5do0zl3ue7H9OYCPQnmRqZJH0qs0SgopozKxaVQIYTOJHuMC7Dk_kP2jZO84PW7W5tBemJoP0b5wo8gIz2sKcHohvTGjhv4an426fBOTzANYopbehM7fHs7oUUqFHsWoIEQUb_aylk7KN2bfnc9Hd0Tm3bWSNzVsSEK7K3Wn1WlgF9Lak9_di_Oyay5vkR3_-_qewHIjT9lW7U-rsOCqp_Awbybgn4Hedu6UNVDWH4yK1xmClu2EjVhTRotHTv6wLWMwqRGLwrIvI4KMj6l_l2H5kA3GoT0Sm3iGEpR9p80naPgcjnZ3Dr_2o6ZHQ2RwwBNMcC5LYx97bwxGt3dSxM6mykmjhLUF1ivCykyg0DTKlwLlje8VShYudb0YbV7AYjWp3CtgNOfJvceKzroktrIokjj2KN8kihhRqg58ur5T2jQAc-qjcaJr9DLXNGI6jFgHPrS2pzW2416r9esbrpvQnWqOJRSqZEwgHXjfHsago5mUonKTC7JBJcW5SvAnXtb-0Z5GJIRYFGkHsjnPaQ0I6D1_pBr9DGBvLJ1REeOFfg6O8Zd_rvfy4SB8ev0vxu_gUf8w39f7g4Nva_CY01aOsPR4HRbRV9wbFFjn5dsQRldKDCE3 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIlVceD8CBRbBBSSn8e563ZW4FNKoKaSqIir1glb2PmhK40S0PcCvZ2btOIQiJLhZ2rG9jxnPN96dbwBeCR1ErkueqKCzRBZKJaV0WVII4XKFGuMj2fPoQO0dyf3j7HgN3i5yYWp-iPaHG1lG_F6Tgc9d2FqShp5Ov026fBt9zDW4LlVPU-GG_nhJHqV1LFGMAEIk6XYvb8lJ-dby3lV3dAVjXj0q-SuEjT5ocAs-L3pfHz352r28KLv2x2_Ejv87vNtwswGnbKfWpjuw5qu7sDFqtt_vgel7P2cNJesXRqHrkoCW7cY0rHNGR0fOvrMda9GlEROFY-8mRDE-pepdlo3GbDiNxZHYLDAEoOyQUk9Q8D4cDXY_vd9LmgoNiUWgJdG9-TxLQxqCtWjbwSuRepdpr6wWzhUYrQincoEw0-pQCgQ3oVdoVfjM91KUeQDr1azyj4DRjicPAeM552XqVFHINA0I3hRCGFHqDrxeLJSxDX05VdE4MzXxMjc0YybOWAdetrLzmrTjj1Kbi_U2jeGeG44BFGJkdB8deNE2o8nRPkpR-dklySCO4lxLfMTDWj3a1whJBIsi60C-ojitANF5r7ZUk5NI642BM-JhHOibqBd_6bnZH42H8erxvwg_h43D_sB8HB58eAI3OOVxxHPHm7COquKfIrq6KJ9FI_oJ1QEf5g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Deep+Learning+Reconstruction+Enables+Highly+Accelerated+Biparametric+MR+Imaging+of+the+Prostate&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Johnson%2C+Patricia+M&rft.au=Tong%2C+Angela&rft.au=Donthireddy%2C+Awani&rft.au=Melamud%2C+Kira&rft.date=2022-07-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1053-1807&rft.eissn=1522-2586&rft.volume=56&rft.issue=1&rft.spage=184&rft.epage=195&rft_id=info:doi/10.1002%2Fjmri.28024&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon |